Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 16, 2022

SELL
$1.09 - $1.67 $15,873 - $24,320
-14,563 Reduced 48.97%
15,177 $17,000
Q2 2022

Aug 16, 2022

SELL
$1.13 - $3.69 $32,173 - $105,061
-28,472 Reduced 48.91%
29,740 $44,000
Q1 2022

May 24, 2022

BUY
$2.85 - $3.73 $165,904 - $217,130
58,212 New
58,212 $192,000
Q2 2021

Aug 19, 2021

SELL
$4.26 - $6.5 $76,156 - $116,200
-17,877 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$5.03 - $8.8 $89,921 - $157,317
17,877 New
17,877 $111,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.